Deferataj 250mg Tablet DT
Prescription Required
Product introduction
Deferataj 250mg Tablet DT is a medicine used in the treatment of chronic iron overload caused by frequent blood transfusion. It helps remove the excess iron from the body and reduce the risk of it causing organ damage.
Repeated blood transfusions in some patients can cause a build-up of excess iron. Deferataj 250mg Tablet DT is used to remove the excess iron from the body
Repeated blood transfusions in some patients can cause a build-up of excess iron. Deferataj 250mg Tablet DT is used to remove the excess iron from the body
Uses of Deferataj Tablet DT
Benefits of Deferataj Tablet DT
In Treatment of Iron overload
Iron overload, as the name suggests, means excess of iron in the human body. Too much iron can cause organ damage, which can lead to conditions such as cancer, irregular heartbeat and cirrhosis of the liver. Symptoms are related to conditions that arise from iron overload such as high blood sugar levels (diabetes), darkening of the skin, abnormal heart rhythm or arthritis. By using Deferataj 250mg Tablet DT, this excess of iron can be decreased to safe levels by removing it from the body through stools. This helps to reduce the risk of organ damage and prevents further complications. Take Deferataj 250mg Tablet DT as prescribed by the doctor to get the maximum benefit.
Side effects of Deferataj Tablet DT
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Deferataj
- Nausea
- Headache
- Vomiting
- Rash
- Abdominal pain
- Constipation
- Itching
- Increased liver enzymes
- Abdominal distension
- Diarrhea
How to use Deferataj Tablet DT
Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Deferataj 250mg Tablet DT is to be taken empty stomach.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Deferataj 250mg Tablet DT. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Deferataj 250mg Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Deferataj 250mg Tablet DT is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Deferataj 250mg Tablet DT may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
UNSAFE
Deferataj 250mg Tablet DT is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
Liver
CAUTION
Deferataj 250mg Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Deferataj 250mg Tablet DT may be needed. Please consult your doctor.
Limited information is available on the use of Deferataj 250mg Tablet DT in these patients.
Limited information is available on the use of Deferataj 250mg Tablet DT in these patients.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Deferataj 250mg Tablet DT is used to reduce excess iron from the body.
- Inform your doctor if you also have upper stomach pain, clay-colored stools, or jaundice (yellowing of your skin or the whites of your eyes).
- Take an adequate amount of water while taking Deferataj 250mg Tablet DT.
- Deferataj 250mg Tablet DT may cause dizziness. It is advisable not to drive or operate any machinery until you feel normal again.
- If you are taking any antacid, take them 2 hours before or after Deferataj 250mg Tablet DT.
- Inform your doctor if you have any liver or kidney disease.
- Inform your doctor if you are pregnant or breastfeeding.
Fact Box
Chemical Class
Triazole & benzoate derivative
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Iron chelating agents
Patient concerns
FAQs
What is Deferataj 250mg Tablet DT used for?
Deferataj 250mg Tablet DT is used for removing excess iron from the body due to repeated blood transfusions in patients with beta thalassemia major (a blood disorder)
How does Deferataj 250mg Tablet DT work?
Deferataj 250mg Tablet DT works by binding to excess iron in the blood and removing it from the body through stool.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Byrns MC, Penning TM. Environmental Toxicology: Carcinogens and Heavy Metals. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1875-76.
- Kosnett MJ. Heavy Metal Intoxication & Chelators. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1010.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 365.
- Deferasirox. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2006 [revised 23 Jul. 2018]. [Accessed 6 Apr. 2019] (online) Available from:
- Medscaape. Deferasirox. [Accessed 6 Apr. 2019] (online) Available from:
- Deferasirox. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2006 [revised 23 Jul. 2018]. [Accessed 25 Jan. 2019] (online) Available from:
- Drugs.com. Deferasirox Pregnancy and Breastfeeding Warnings. [Accessed 6 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 6 Apr. 2019] (online) Available from:
Marketer details
Name: Taj Pharma India Ltd
Address: first floor, 15-6-108 afzal gunj, hyderabad, telangana 500012
Country of origin: India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Deferataj 250mg Tablet DT. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Expires on or after: February, 2025
A licensed vendor partner from your nearest location will deliver Deferataj 250mg Tablet DT. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
In case of any issues, contact us
Email ID: [email protected]Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Lab tests offered by us
Related/Popular tests
₹250.56₹288Get 13% OFF
₹244.8+ free shipping with
Inclusive of all taxes
Get this discount by applying coupon TESTING_REPEAT on the cart. Max. coupon discount is ₹500. T&C apply.
1 Strip
10.0 tablet dt in 1 strip